An ongoing case-control study to evaluate the NHS breast screening programme

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Massat, Nathalie J ^a   Sasieni, Peter D ^a   Parmar, Dharmishta ^a   Duffy, Stephen W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Advanced stage; Bias; Breast cancer; Case control; Incidence; Mortality; Overdiagnosis

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER THERAPY; CASE CONTROL STUDY; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; HUMAN; MEDICAL HISTORY; NATIONAL HEALTH SERVICE; OBSERVATIONAL STUDY; PATHOLOGY; SELECTION BIAS; UNITED KINGDOM;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; GREAT BRITAIN; HUMANS; MAMMOGRAPHY; MASS SCREENING; NATIONAL HEALTH PROGRAMS; QUALITY ASSURANCE, HEALTH CARE; RESEARCH DESIGN;

EID: 84890008191     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-596     Document Type: Article

References (26)

1. Cancer Research UK Breast cancer statistics. Cancer Research UK 2010, http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast] (Accessed 28/03/13, Cancer Research UK.
2. Verbeek AL, Broeders MJ. Evaluation of cancer service screening: case referent studies recommended. Stat Methods Med Res 2010, 19:487-505. 10.1177/0962280209359856, 20356858.
3. Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 2008, 98(1):206-209. 10.1038/sj.bjc.6604123, 2359716, 18059396.
4. Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, Duffy SW. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 2004, 11:194-198. 10.1258/0969141042467304, 15563774.
5. Walter SD. Mammographic screening: case-control studies. Ann Oncol 2003, 14:1190-1192. 10.1093/annonc/mdg320, 12881374.
6. Duffy SW, Cuzick J, Tabar L, Vitak B, Hsiu-Hsi Chen T, Yen M-F, Smith RA. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. J R Stat Soc: Ser C: Appl Stat 2002, 51:235-243.
7. Paci E. Summary of the evidence of breast cancer service screening outcomes in Europe and first estimate of the benefit and harm balance sheet. J Med Screen 2012, 19(Suppl 1):5-13.
8. Cancer Intervention Surveillance Modeling Network (CISNET) Breast Cancer Collaborators Executive summary. JNCI Monogr 2006, 2006(36):1-2. Cancer Intervention Surveillance Modeling Network (CISNET) Breast Cancer Collaborators.
9. Advisory Committee on Breast Cancer Screening Screening for breast cancer in England: past and future. NHS Cancer Screen Programme 2006, 61. http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp61.html (Accessed August 2013), Advisory Committee on Breast Cancer Screening.
10. Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH. The randomized trials of breast cancer screening: what have we learned?. Radiol Clin North Am 2004, 42(5):793-806. 10.1016/j.rcl.2004.06.014, 15337416.
11. Broeders M, Moss S, Nystrom L, Njor S, Jonsson H, Paap E, Massat N, Duffy S, Lynge E, Paci E. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 2012, 19(Suppl 1):14-25.
12. Machin D, Campbell M, Fayers P, Pinol A. Sample Size Tables for Clinical Studies. 1997, Oxford: Blackwell.
13. Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA. Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England. J Med Screen 2010, 17:25-30. 10.1258/jms.2009.009094, 3104821, 20356942.
14. Connor RJ, Boer R, Prorok PC, Weed DL. Investigation of Design and Bias Issues in Case-Control Studies of Cancer Screening Using Microsimulation. Am J Epidemiol 2000, 151:991-998. 10.1093/oxfordjournals.aje.a010143, 10853638.
15. Duffy SW, Olsen A-H, Gabe R, Tabar L, Warwick J, Fielder H, Tryggvadóttir L, Agbaje OF. Screening opportunity bias in case-control studies of cancer screening. J Appl Stat 2008, 35:537-546.
16. Puliti D, Miccinesi G, Paci E. Overdiagnosis in breast cancer: Design and methods of estimation in observational studies. Prev Med 2011, 53:131-133. 10.1016/j.ypmed.2011.05.012, 21658405.
17. Health and Social Care Information Centre (HSCIC) Screening and Immunisations team Breast Screening Programme England 2011-12 report. Health and Social Care Information Centre (HSCIC) 2013, http://www.hscic.gov.uk/catalogue/PUB10339] (Accessed August 2013, Health and Social Care Information Centre (HSCIC) Screening and Immunisations team.
18. Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdottir GH, Sigurdsson K, Duffy SW. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 2007, 48:948-955. 10.1080/02841850701501725, 18080359.
19. Duffy SW, Nagtegaal ID, Wallis M, Cafferty FH, Houssami N, Warwick J, Allgood PC, Kearins O, Tappenden N, O'Sullivan E, et al. Correcting for Lead Time and Length Bias in Estimating the Effect of Screen Detection on Cancer Survival. Am J Epidemiol 2008, 168:98-104. 10.1093/aje/kwn120, 18504245.
20. Tabar L, Vitak B, Chen HH, Duffy SW, Yen MF, Chiang CF, Krusemo UB, Tot T, Smith RA. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000, 38:625-651. 10.1016/S0033-8389(05)70191-3, 10943268.
21. Biesheuvel C, Barratt A, Howard K, Houssami N, Irwig L. Effects of study methods and biases on estimates of invasive breast cancer overdetection with mammography screening: a systematic review. Lancet Oncol 2007, 8:1129-1138. 10.1016/S1470-2045(07)70380-7, 18054882.
22. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 2009, 339:b2968. 10.1136/bmj.b2968, 2718082, 19638651.
23. Wishart GC, Greenberg DC, Chou P, Brown CH, Duffy S, Purushotham AD. Treatment and survival in breast cancer in the Eastern Region of England. Ann Oncol 2010, 21:291-296. 10.1093/annonc/mdp301, 2813304, 19502647.
24. Hofler M. Causal inference based on counterfactuals. BMC Med Res Methodol 2005, 5:28. 10.1186/1471-2288-5-28, 1239917, 16159397.
25. Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, Field JK. The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 2008, 98:270-276. 10.1038/sj.bjc.6604158, 2361453, 18087271.
26. Independent UK Panel on Breast Cancer Screening The benefits and harms of breast cancer screening: an independent review. Lancet 2012, 380(9855):1778-1786. Independent UK Panel on Breast Cancer Screening.